摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(内-5-降冰片烯-2,3-二羧酰亚胺)-1,1,3,3-四甲基脲六氟磷酸盐 | 125700-68-7

中文名称
2-(内-5-降冰片烯-2,3-二羧酰亚胺)-1,1,3,3-四甲基脲六氟磷酸盐
中文别名
——
英文名称
Methanaminium, 1-(dimethylamino)-N,N-dimethyl-1-[(4-oxo-1,2,3-benzotriazin-3(4H)-yl)oxy]-
英文别名
[dimethylamino-[(4-oxo-1,2,3-benzotriazin-3-yl)oxy]methylidene]-dimethylazanium
2-(内-5-降冰片烯-2,3-二羧酰亚胺)-1,1,3,3-四甲基脲六氟磷酸盐化学式
CAS
125700-68-7
化学式
C12H16N5O2+
mdl
——
分子量
262.29
InChiKey
VUWHVUNQPYWNDG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1
  • 重原子数:
    19
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    60.5
  • 氢给体数:
    0
  • 氢受体数:
    4

文献信息

  • [EN] 3-HYDROXY-4-OXO-1,2,3-TRIAZINES AND DERIVATIVES THEREOF FOR AMIDE AND ESTER BOND FORMATION<br/>[FR] 3-HYDROXY-4-OXO-1,2,3-TRIAZINES ET LEURS DERIVES POUR LA FORMATION DE LIAISONS AMIDE ET ESTER
    申请人:FRUTAROM LTD
    公开号:WO2005007634A1
    公开(公告)日:2005-01-27
    The present invention relates to the use of a compound of formula I as a coupling reagent in forming amide or ester bonds from a reaction between a carboxylic acid and an amine or an alcohol, respectively. The compounds of formula I are especially useful as coupling reagents in the preparation of peptide bonds during peptide synthesis. In particular, the compounds of formula I are useful in promoting the formation of reactive reaction intermediates, inhibiting side reactions and in suppression of racemization. In addition, the present invention provides novel compounds of Formula I, and salts of N-oxides thereof.
    本发明涉及在羧酸与胺或醇之间的反应中,将式I化合物用作偶联试剂形成酰胺或酯键。式I化合物在肽合成过程中特别有用作为偶联试剂。具体来说,式I化合物有助于促进反应中间体的形成,抑制副反应和消除旋光异构化。此外,本发明提供了式I的新化合物及其N-氧化物盐。
  • Process for the synthesis of amide bonds with the aid of novel catalysts
    申请人:Merck Patent GmbH
    公开号:US10544186B2
    公开(公告)日:2020-01-28
    The invention relates to a process for the production of amide bonds, in particular peptide bonds, with the aid of novel amide linking reagents containing an anion of the formula (I), to the novel reagents, and to the preparation thereof.
    该发明涉及一种利用含有公式(I)阴离子的新型酰胺连接试剂生产酰胺键的方法,特别是肽键的方法,涉及新型试剂及其制备方法。
  • [EN] PNA MONOMER AND PRECURSOR<br/>[FR] MONOMÈRE DE PROTÉINE PNA ET PRÉCURSEUR
    申请人:PANAGENE INC
    公开号:WO2005009998A1
    公开(公告)日:2005-02-03
    This application relates to monomers of the general formula (I) for the preparation of PNA (peptide nucleic acid) oligomers and provides method for the synthesis of both predefined sequence PNA oligomers and random sequence PNA oligomers,wherein E is sulfur or oxygen; J is nitrogen or C-R'; R1, R' is independently H, halogen, alkyl, nitro, nitrile, alkoxy, halogenated alkyl, halogenated alkoxy or a functional group having one of following general formulae (A, B) wherein A1, A2, A3, A4, A5, is independently selected from H, halogen such as F, Cl, Br or I, CF3, alkyl, preferably C1,-C4 alkyl, nitro, nitrile, alkoxy, preferably C1,-C4 alkoxy, halogenated (such as F, Cl, Br and I) alkyl, preferably halogenated C1-C4 alkyl, halogenated (such as F, Cl, Br and I) alkoxy, preferably halogenated Ci-C4 alkoxy, phenyl, and halogenated (such as F, Cl, Br and I) phenyl; R2 is H or protected or unprotected side chain of natural or unnatural α-amino acid; and B is a natural or unnatural nucleobase, wherein when said nucleobase has an exocyclic amino function, said function is protected by protecting group which is labile to acids but stable to weak to medium bases in the presence of thiol.
    该应用涉及通用式(I)的单体,用于制备PNA(肽核酸)寡聚体,并提供了合成预定义序列PNA寡聚体和随机序列PNA寡聚体的方法,其中E为硫或氧;J为氮或C-R';R1、R'独立取H、卤素、烷基、硝基、腈基、烷氧基、卤代烷基、卤代烷氧基或具有以下通用式(A、B)之一的功能基团,其中A1、A2、A3、A4、A5独立选择自H、氟、氯、溴或碘等卤素、三氟甲基、烷基,优选C1-C4烷基、硝基、腈基、烷氧基,优选C1-C4烷氧基、卤代(如氟、氯、溴和碘)烷基,优选卤代C1-C4烷基、卤代(如氟、氯、溴和碘)烷氧基,优选卤代C1-C4烷氧基,苯基和卤代(如氟、氯、溴和碘)苯基;R2为H或天然或非天然α-氨基酸的保护或未保护侧链;B为天然或非天然核碱基,其中当所述核碱基具有外环氨基功能时,所述功能由对酸敏感但在巯基存在的弱到中等碱存在下稳定的保护基团保护。
  • Process for the synthesis of (2s, 3as, 7as)-1-[(s)-alanyl]-octahydro-1h-indole-2-carboxylic acid compounds and application in the synthesis of perindopril
    申请人:Dubuffet Thierry
    公开号:US20070123581A1
    公开(公告)日:2007-05-31
    Process for the synthesis of compounds of formula (I): wherein R represents a hydrogen atom or a protecting group for the amino function. Application in the synthesis of perindopril and pharmaceutically acceptable salts thereof.
    合成式(I)化合物的过程: 其中R代表氢原子或氨基功能的保护基团。应用于Perindopril及其药学上可接受的盐的合成。
  • PNA monomer and precursor
    申请人:Kim Kee Sung
    公开号:US20050250785A1
    公开(公告)日:2005-11-10
    This application relates to monomers of the general formula (I) for the preparation of PNA (peptide nucleic acid) oligomers and provides method for the synthesis of both predefined sequence PNA oligomers and random sequence PNA oligomers: wherein E is nitrogen or C—R′; J is sulfur or oxygen; R′, R1, R2, R3, R4 is independently H, halogen, alkyl, nitro, nitrile, alkoxy, halogenated alkyl, halogenated alkoxy, phenyl or halogenated phenyl, R5 is H or protected or unprotected side chain of natural or unnatural α-amino acid; and B is a natural or unnatural nucleobase, wherein when said nucleobase has an exocyclic amino function, said function is protected by protecting group which is labile to acids but stable to weak to medium bases in the presence of thiol.
    本申请涉及通式(I)的单体,用于制备PNA(肽核酸)寡聚体,并提供预定义序列PNA寡聚体和随机序列PNA寡聚体的合成方法:其中E为氮或C-R′;J为硫或氧;R′、R1、R2、R3、R4独立地为H、卤素、烷基、硝基、腈基、烷氧基、卤代烷基、卤代烷氧基、苯基或卤代苯基,R5为H或天然或非天然α-氨基酸的保护或未保护侧链;B为天然或非天然核碱基,其中当所述核碱基具有外环氨基功能时,所述功能由易于酸性但对弱到中等碱稳定的保护基保护。
查看更多

同类化合物

苯并咪唑并[1,2-C][1,2,3]苯并三嗪 硫代磷酸 O,O-二甲基 S-((4-氧代-1,2,3-苯并三嗪-3(4H)-基)甲基)酯 益棉磷 吗林那宗 保棉磷 N,N,N',N'-四甲基-O-(3,4-二氢-4-氧代-1,2,3-苯并三嗪-3-基)脲四氟硼酸盐(TDBTU) 8-甲氧基苯并[D][1,2,3]三嗪-4(3H)-酮 7-甲硫基-8,9,10-三氮杂双环[4.4.0]癸-1,3,5,7,9-五烯 7-乙氧基-6-甲氧基-4-(4-三氟甲基苯胺基)-1,2,3-苯并三嗪 7-乙氧基-6-甲氧基-4-(3-三氟甲基苯胺基)-1,2,3-苯并三嗪 7-乙氧基-4-(4-氟-3-三氟甲基苯胺基)-6-甲氧基-1,2,3-苯并三嗪 7-乙氧基-4-(3-氟-4-溴苯胺基)-6-甲氧基-1,2,3-苯并三嗪 7-乙氧基-4-(2-氟苯胺基)-6-甲氧基-1,2,3-苯并三嗪 6-硝基-1,2,3-苯并三嗪-4(1H)-酮2-氧化物 6-甲氧基-4-(4-氟苯胺基)-7-戊氧基-1,2,3-苯并三嗪 6-氟苯并[D][1,2,3]三嗪-4(1H)-酮 6-氟-3-羟基-1,2,3-苯并三嗪-4-酮 5-氯苯并[D][1,2,3]三嗪-4(3H)-酮 5-氟苯并[D][1,2,3]三嗪-4(3H)-酮 4-(4-甲氧基苯基)-1,2,3-苯并三嗪 4-(4-溴-3-氟苯胺基)-6-甲氧基-7-戊氧基-1,2,3-苯并三嗪 4-(3-氯-4-氟苯基氨基)-苯并[d] [1,2,3]三嗪 4-(3,5-二氟苯胺基)-6-甲氧基-7-戊氧基-1,2,3-苯并三嗪 3-苯基-1,2,3-苯并三嗪-4(3H)-酮 3-羟基甲基-4-酮苯并-1,2,3-噻嗪 3-羟基-8-(三氟甲基)苯并[D][1,2,3]三嗪-4(3H)-酮 3-羟基-7-甲基-1,2,3-苯并三嗪-4-酮 3-羟基-6-甲基苯并[D][1,2,3]三嗪-4(3H)-酮 3-羟基-1,2,3-苯并三嗪-4(3H)-酮 3-甲基苯并三嗪-4-酮 3-环己基-1,2,3-苯并三嗪-4-酮 3-氯甲基-3-苯并噻嗪-4(3H)-酮 3-哌啶-4-基-3H-苯并[d] [1,2,3]三嗪-4-酮 3-吡啶-2-基-1,2,3-苯并三嗪-4-酮 3-丙-2-烯基-1,2,3-苯并三嗪-4-酮 3-丁氧基-1,2,3-苯并三嗪-4-酮 3-[(甲氧基-甲硫基磷酰)巯基甲基]-1,2,3-苯并三嗪-4-酮 3-(氯甲氧基)-1,2,3-苯并三嗪-4-酮 3-(哌啶-4-基)苯并[D][1,2,3]三嗪-4(3H)-酮盐酸盐 3-(二乙氧基邻酰氧基)-1,2,3-苯并三嗪-4-酮 3-(二乙氧基磷酰硫基甲基)-1,2,3-苯并三嗪-4-酮 3-(4-溴苯基)-1,2,3-苯并三嗪-4(3H)-酮 3-(4-氧代-1,2,3-苯并三嗪-3(4H)-基)丙酸 3-(2-苯基乙烯基)-1,2,3-苯并三嗪-4-酮 3-(2-甲基吡唑-3-基)-1,2,3-苯并三嗪-4-酮 3-(2-溴苯基)-1,2,3-苯并三嗪-4-酮 3-(1-乙氧基乙基)-1,2,3-苯并三嗪-4-酮 3,4-二氢-4-亚氨基-3-丙基-1,2,3-苯并三嗪 2-(内-5-降冰片烯-2,3-二羧酰亚胺)-1,1,3,3-四甲基脲六氟磷酸盐 2-(4-氧代-4H-苯并[d] [1,2,3]三嗪-3-基)-苯甲酸